GPC2-CAR T cells have potent preclinical activity against orthotopic medulloblastoma xenografts.
Okada R, Fanuzzi M, Rodriguez C, Oh J, Sreenivasan A, Stack HG, Puebla M, Phadke I, Cole AP, Bradford S, Kelly MC, Lei H, Ho M, Cotter JA, Thiele CJ, Zhang X, Nellan A, Nguyen R.
Okada R, et al. Among authors: stack hg.
Mol Ther Oncol. 2025 Sep 30;33(4):201067. doi: 10.1016/j.omton.2025.201067. eCollection 2025 Dec 18.
Mol Ther Oncol. 2025.
PMID: 41159102
Free PMC article.